ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,522, issued on June 23, was assigned to XLIFESC LTD. (Zhuhai, China). "High-affinity TCR for recognizing SSX2 antigen" was invented by Shao... Read More
ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,523, issued on June 23, was assigned to FIVE PRIME THERAPEUTICS INC. (Thousand Oaks, Calif.). "Pharmaceutical formulations containing CD80 ... Read More
ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,524, issued on June 23, was assigned to NATIONAL CENTRE FOR CELL SCIENCE (Maharashtra, India). "DAF-MCP chimeric proteins, process to manuf... Read More
ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,525, issued on June 23, was assigned to Ablynx N.V. (Ghent-Zwijnaarde, Belgium) and Sanofi (Paris). "Techniques for predicting, detecting a... Read More
ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,526, issued on June 23, was assigned to Chugai Seiyaku K.K. (Tokyo) and Agency for Science Technology & Research (Singapore). "Anti-dengue ... Read More
ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,527, issued on June 23, was assigned to Ablynx NV (Ghent-Zwijnaarde, Belgium) and Sanofi (Paris). "Serum albumin binding immunoglobulin sin... Read More
ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,528, issued on June 23, was assigned to NovaGo Therapeutics AG (Schlieren, Switzerland). "Anti-Nogo-A antibodies and methods of making and ... Read More
ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,529, issued on June 23, was assigned to FYB202 PROJECT GMBH (Berlin). "Production of biosimilar ustekinumab in CHO cells" was invented by S... Read More
ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,530, issued on June 23, was assigned to SPHINGOTEC GMBH (Hennigsdorf, Germany). "Anti-ADM-antibodies binding to the free N-terminus for acc... Read More
ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,531, issued on June 23, was assigned to FUTUREGEN BIOPHARMACEUTICAL (BEIJING) Co. LTD. (Beijing). "CLDN18.2 antibody and use thereof" was i... Read More